Search

everythinglearnresearchcommunity

for

Search:↓

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Autoimmune conditions can be linked to trichoepitheliomas, with treatment focusing on cosmetic concerns.

Alopecia areata patients are more likely to develop systemic lupus erythematosus.

Baricitinib improved hair loss and arthritis in a lupus patient.

The treatment led to significant hair regrowth in a lupus patient.

The patient with lupus and Degos' disease showed significant improvement with treatment.

Belimumab may cause hair loss in lupus patients.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Active treatment can help prevent scarring hair loss in SLE patients.

Shiny white structures in trichoscopy can indicate long-standing discoid lupus erythematosus alopecia.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Hair loss from chronic cutaneous lupus erythematosus can sometimes be reversed with early, aggressive treatment.

Hair loss can occur in people with systemic lupus erythematosus.

Phenytoin, a medication, can cause hair loss and trigger a condition similar to lupus.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Alopecia in lupus patients is often underdiagnosed and rarely biopsied.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.